Sweden: Sensidose preparing to IPO on Spotlight Stock Market

Sensidose, a pharmaceutical company that develops and sells individualized dosage of tablets for optimal medical treatment of Parkinson’s disease, is preparing to list shares on the Spotlight Stock Market this spring. The company is raising funds in order to expand the market for its existing product, Flexilev in combination with the dosing device MyFID, which…

You must be a HMI Subscriber to view this content.

Subscribe Now »